Enhanced biological activity of antisense oligonucleotides complexed with glycosylated poly-L-lysine

Molecular Pharmacology

Volumn 50, Issue 6, 1996, Pages 1487-1494

  Stewart, A J ^a,b   Pichon, C ^a   Meunier, L ^a   Midoux, P ^a   Monsigny, M ^a   Roche, A C ^a,c  

^a UNIVERSITÉ D'ORLÉANS   (France)

^b Cantab Pharmaceuticals Ltd   (United Kingdom)

^c CENTRE DE BIOPHYSIQUE MOLÉCULAIRE   (France)

Author keywords

[No Author keywords available]

Indexed keywords

ANTISENSE OLIGODEOXYNUCLEOTIDE; CARBOHYDRATE BINDING PROTEIN; CHLOROQUINE; INTERCELLULAR ADHESION MOLECULE 1; LIPOSOME;

AMINO ACID ANALYSIS; AMINO ACID SEQUENCE; AMINO ACID TRANSPORT; ARTICLE; DRUG DELIVERY SYSTEM; FUCOSYLATION; GENE EXPRESSION; GENETIC CODE; GLYCOSYLATION; PRIORITY JOURNAL;

CHLOROQUINE; DRUG INTERACTIONS; ENDOCYTOSIS; GLYCOSYLATION; HUMANS; INTERCELLULAR ADHESION MOLECULE-1; OLIGONUCLEOTIDES, ANTISENSE; POLYLYSINE; TUMOR CELLS, CULTURED;

EID: 0030479079     PISSN: 0026895X     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Article

References (39)

1. Crooke, S. T. Therapeutic applications of oligonucleotides. Annu. Rev. Pharmacol. Toxicol. 32:329-376 (1992).
2. Loke, S. L., C. A. Stein, X. H. Zhang, K. Mori, M. Nakanishi, C. Subasinghe, J. S. Cohen, and L. M. Neckers. Characterization of oligonucleotide transport into living cells. Proc. Natl. Acad. Sci. USA 86:3474-3478 (1989).
3. Vlassov, V. V., L. A. Balakireva, and L. A. Yakubov. Transport of oligonu-cleotides across natural and model membranes. Biochim. Biophys. Acta 1197:95-108 (1994).
4. Krieg, A. M., J. Tonkinson, S. Matson, Q. Zhao, M. Saxon, L. M. Zhang, U. Bhanja, L. A. Yakubov, and C. A. Stein. Modification of antisense phosphodiester oligodeoxynucleotides by a 5′ cholesteryl moiety increases cellular association and improves efficacy. Proc. Natl. Acad. Sci. USA 90: 1048-1052 (1993).
5. Bennett, C. F., M.-Y. Chiang, H. Chan, J. E. E. Shoemaker, and C. K. Mirabelli. Cationic lipids enhance cellular uptake and activity of phosphorothioate antisense oligonucleotides. Mol. Pharmacol. 41:1023-1033 (1992).
6. Leonetti, J. P., P. Machy, G. Degols, B. Lebleu, and L. Leserman. Antibody-targeted liposomes containing oligodeoxynucleotides complementary to viral RNA selectively inhibit viral replication. Proc. Natl. Acad. Sci. USA 87:2448-2451 (1990).
7. Bonfils, E., C. Depierreux, P. Midoux, N. T. Thuong, M. Monsigny, and A. C. Roche. Drug targeting: synthesis and endocytosis of oligonucleotide-neoglycoprotein conjugates. Nucleic Acids Res. 20:4621-4629 (1992).
8. Reinis, M., D. Damkova, and E. Korec. Receptor-mediated transport of oligodeoxynucleotides into hepatic cells. J. Virol. Methods 42:99-106 (1993).
9. Deshpande, D., D. Toledo-Velasquez, D. Thakkar, W. W. Liang, and Y. Rojanasakul. Enhanced cellular uptake of oligonucleotides by EGF receptor-mediated endocytosis in A549 cells. Pharmacol. Res. 13:57-61 (1996).
10. Liang, W. W., X. Shi, D. Deshpande, C. J. Malanga, and Y. Rojanasakul. Oligonucleotide targeting to alveolar macrophages by mannose receptor-mediated endocytosis. Biochim. Biophys. Acta 1279:227-234 (1996).
11. Wu, G. H., and C. H Wu. Specific inhibition of hepatitis B viral gene expression in vitro by target antisense oligonucleotides. J. Biol. Chem. 267:12436-12439 (1992).
12. Citro, G., D. Perrotti, C. Cucco, I. D'Agnano, A. Sacchi, G. Zupi, and B. Calabretta. Inhibition of leukemia cell proliferation by receptor-mediated uptake of c-myc antisense oligodeoxynucleotides. Proc. Natl. Acad. Sci. USA 89:7031-7035 (1992).
13. Citro, G., C. Szczylik, P. Ginobbi, G. Zupi, and B. Calabretta. Inhibition of leukemia cell proliferation by folic acid-polylysine-mediated introduction of c-myb antisense oligodeoxynucleotides into HL60 cells. Br. J. Cancer 69:463-467 (1994).
14. Sdiqui, N., K. Arar, P. Midoux, M. Monsigny, and A. C. Roche. Inhibition of human mammary cell line proliferation by membrane lectin-mediated uptake of Ha-ras antisense oligonucleotide. Drug Delivery 2:63-72 (1995).
15. Monsigny, M., C. Kieda, and A. C. Roche. Membrane glycoproteins, glycolipids and membrane lectins as recognition signals in normal and malignant cells. Biol. Cell 47:95-110 (1983).
16. Monsigny, M., A. C. Roche, and P. Midoux. Endogenous lectins and drug targeting. Ann. N. Y. Acad. Sci. 551:399-414 (1988).
17. Fiume, L., C. Busi, G. Di Stefani, and A. Mattioli. Targeting of antiviral drugs to the liver using glycoprotein carriers. Adv. Drug Delivery Rev. 14:51-66 (1994).
18. Frese, J., C. H. Wu, and G. Y. Wu. Targeting of genes to the liver with glycoprotein carriers. Adv. Drug Delivery Rev. 14:137-152 (1994).
19. Monsigny, M., A. C. Roche, P. Midoux, and R. Mayer. Glycoconjugates as carriers for specific delivery of therapeutic drugs and genes. Adv. Drug Delivery Rev. 14:1-24 (1994).
20. Roche, A. C., M. Barzilay, P. Midoux, S. Junqua, N. Sharon, and M. Monsigny. Sugar-specific endocytosis of glycoproteins by Lewis lung carcinoma cells. J. Cell. Biochem. 22:131-140 (1983).
21. Chiang, M. Y., H. Chan, M. A. Zounes, S. M. Freier, W. F. Lima, and C. F. Bennett. Antisense oligonucleotides inhibit intercellular adhesion molecule-1 expression by two distinct mechanisms. J. Biol. Chem, 266:18162-18171 (1991).
22. Erbacher, P., A. C. Roche, M. Monsigny, and P. Midoux. Putative role of chloroquine in gene transfer into a human hepatoma cell line by DNA/ lactosylated polylysine complexes. Exp. Cell Res. 225:186-194 (1996).
23. Stewart, A. J., C. Pichon, A. M. Aubertin, P. Midoux, R. Mayer, M. Monsigny, and A. C. Roche. Fluorescent labelling of non-modified phosphorothioate oligodeoxynucleotides: synthesis and characterization. N. J. Chem., in press.
24. Maxfield, F. R. Weak bases and ionophores rapidly and reversibly raise the pH of endocytic vesicles in cultured mouse fibroblasts. J. Cell Biol. 95: 676-681 (1982).
25. Midoux, P., A. C. Roche, and M. Monsigny. Quantitation of the binding, uptake and degradation of fluoresceinylated neoglycoproteins by flow cytometry. Cytometry 8:327-334 (1987).
26. Midoux, P., C. Mendes, A. Legrand, J. Raimond, R. Mayer, M. Monsigny, and A. C. Roche. Specific gene transfer mediated by lactosylated poly-L-lysine into hepatoma cells. Nucleic Acids Res. 21:871-878 (1993).
27. Monsigny, M., C. Petit, and A. C. Roche. Colorimetric determination of neutral sugars by resorcinol sulfuric acid micromethod. Anal. Biochem. 175:525-530 (1988).
28. Mosmann, T. Rapid colorimetric assay for cellular growth and survival: application to proliferation and cytotoxicity. J. Immunol. Methods 65: 55-63 (1983).
29. Lowry, O. H., N. J. Roseburgh, A. L. Farr, and R. J. Randall. Protein measurement with the folin phenol reagent. J. Biol. Chem. 193:265-275 (1951).
30. Johnson, G. D., R. S. Davidson, K. C. McNamee, G. Russell, D. Goodwin, and E. J. Holborow. Fading of immunofluorescence during microscopy: a study of the phenomenon and its remedy. J. Immunol. Methods 55:231-242 (1982).
31. Arnold, L. J., A. Dagan, J. Gutheil, and N. O. Kaplan. Antineoplastic activity of poly(L-lysine) with some ascites tumor cells. Proc. Natl. Acad. Sci. USA 76:3246-3250 (1979).
32. Lemaitre, M., B. Bayard, and B. Lebleu. Specific antiviral activity of a poly(L-lysine)-conjugated oligodeoxyribonucleotide sequence complementary to vesicular somatitis virus N protein mRNA initiation site. Proc. Natl. Acad. Sci. USA 84:648-652 (1987).
33. Degols, G., J. P. Leonetti, M. Benkirane, C. Devaux, and B. Lebleu. Poly(L-lysine)-conjugated oligonucleotides promote sequence-specific inhibition of acute HIV-1 infection. Antisense Res. Dev. 2:293-301 (1992).
34. Stein, C. A., and A. M. Krieg. Problems in interpretation of data derived from in vitro and in vivo use of antisense oligodeoxynucleotides. Antisense Res. Dev. 4:67-69 (1994).
35. Burgess, T. L., E. F. Fisher, S. L. Ross, J. V. Bready, Y. X. Qian, L. A. Bayewitch, A. M. Cohen, C. J. Herrera, S. S. F. Hu, T. B. Kramer, F. D. Lott, F. H. Martin, G. F. Pierce, L. Simonet, and C. L. Farrell. The antiproliferative activity of c-myb and c-myc antisense oligonucleotides in smooth muscle cells is caused by a nonantisense mechanism. Proc. Natl. Acad. Sci. USA 92:4051-4055 (1995).
36. Bunnell, B. A., F. K. Askari, and J. M. Wilson. Targeted delivery of antisense oligonucleotides by molecular conjugates. Somatic Cell Mol. Genet. 18:559-569 (1992).
37. Lamaze, C., and S. Schmid. The emergence of clathrin-independent pinocytic pathways. Curr. Opin. Cell Biol. 7:573-580 (1995).
38. Wagner, E., D. Curiel, and D. Cotten. Delivery of drugs, proteins and genes into cells using transferrin as a ligand for receptor-mediated endocytosis. Adv. Drug Delivery Rev. 14:113-135 (1994).
39. Erbacher, P., A. C. Roche, M. Monsigny, and P. Midoux. Glycosylated polylysine/DNA complexes: gene transfer efficiency in relation with the size and the sugar substitution level of glycosylated polylysines and with the plasmid size. Bioconjugate Chem. 6:401-410 (1995).